Navigation Links
Alquest Announced as MedNet Solutions' First iMedNet CRO Partner

MINNETONKA, Minn., Oct. 18, 2011 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Alquest LLC, a CRO specializing in medical devices, in vitro diagnostics (IVDs), biologics and combination products, are pleased to jointly announce that Alquest has become the first organization to join the iMedNet™ CRO Partner Program.  Introduced last month by MedNet Solutions, the iMedNet CRO Partner Program helps Clinical Research Organizations (CROs) improve research efficiency, expand their service offerings, decrease internal costs and win more business.

"We're delighted to be the first iMedNet CRO Partner with MedNet Solutions," stated Linda Alexander, Chief Executive Officer of Alquest.  "Their new iMedNet EDC solution builds on the success of their proven ENLIGHTEN® software and brings eClinical capabilities to a whole new level.  I'm excited to show this to our clients and provide them with this comprehensive, state-of-the-art solution."

"iMedNet provides us with flexible, easy-to-use tools to reduce our database development timelines and effectively meet our clients' needs," noted Ann Quinlan-Smith, President of Alquest.  "iMedNet is an outstanding EDC solution for study sites as well, with simple screens and easy, yet complete navigation."

"We are extremely happy to have Alquest as our first iMedNet CRO Partner organization," commented John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "Their long, proven track record, sterling reputation and strong focus on customer service are exactly what we are looking for in our CRO partners.  Alquest is just the type of quality organization that many prospective iMedNet customers are looking for to build and manage their studies."  

Please contact MedNet Solutions for more information on the iMedNet CRO Partner Program.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, biotechnology, and contract research organizations on clinical research conducted around the world. MedNet delivers a superior customer experience from beginning to end.  For more information, please visit

About Alquest LLC – a NAMSA Company

Alquest LLC is a NAMSA company.  Founded 17 years ago, Alquest supports medical device manufacturers in the areas of regulatory strategy and submissions; clinical trial design and trial conduct; quality systems; and product safety, biocompatibility and sterilization.  NAMSA is the world's leading medical device-focused contract research organization specialized in safety evaluations. For more information, see and

Contact Information:
Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
(763) 258-2735

Linda S. Alexander
Chief Executive Officer/Founder
Alquest LLC – a NAMSA Company
4050 Olson Memorial Highway, Suite 350
Minneapolis, MN  55422
(763) 287-3830

SOURCE MedNet Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
2. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
3. Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimers Disease Announced
4. PRoFESS(R) Results Announced at XVII European Stroke Conference
5. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
6. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
7. 2008 Human Research Protection Award Recipients Announced
8. Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference
9. Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
10. Biotel Announced Profitable First Quarter Ended September 30, 2009
11. New Executive Leadership and CEO Announced for BiPar Sciences
Post Your Comments:
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):